Furthermore, recent research has demonstrated that CXCR4 is critical for maintaining breast cancer stemness and plays a role in resistance to CDK4/6 inhibitors through the activation of the WNT5A/β-catenin signaling pathway [28]. The gene discussed is CDK4; the disease is breast carcinoma.